Description
Demers Braun Crestline Medix (“DBCM”) was the clear leader in the ambulance manufacturing industry in Canada with a leading position across North America.
Investment
$52.2M
Industry
Manufacturing
Status
Realized
Clearspring Value Add
- M&A: Acquired three competitors, solidifying DBCM’s Canadian leadership, and enabling DBCM to offer value, mid-range and high-end ambulances in the U.S.
- Pricing and SKU Optimization: Rigorous focus on pricing and product optimization across portfolio to drive significant margin expansion.
- US Go To Market Strategy: Developed the organic growth strategy to convert top U.S. ambulance dealers to DBCM.
- Long Term View During COVID: Supported management through COVID challenges, including supply chain shortages, delayed customer shipments, and labour constraints, which significantly impacted company operations and profitability.
1,324%
EBITDA Growth
590%
Revenue Growth
5x
North American market share Gains
RECENTLY VIEWED CASE STUDIES
CBI Health Group | Status Realized
CBI Health was one of the largest rehabilitation companies in Canada with more than 900 clinical and support staff serving in over 225 clinics throughout Canada.
VIEW CASE STUDYLogistik | Status Realized

















